CAMBRIDGE, Mass., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that its development partner, GSK, filed a New Drug Application (NDA) resubmission to the U.S. Food and Drug Administration (FDA) for tebipenem HBr, an investigational oral carbapenem antibiotic being developed for the treatment of co ...

LONG BEACH, Calif. and TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest-growing, vertically-integrated cannabis companies in the U.S., applauds yesterday’s cannabis reform action from the Trump administration. “The executive order to reschedule cannabis to a Schedule III classification and the authorization of a pilot program for Medicare reimbursement of the cannabis ...

Total national coverage footprint for PENFS increases to roughly 100 million covered livesCARMEL, Ind., Dec. 19, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced significant new medical policy coverage from a major national health insurer for Percutaneous Electrical Nerve Field Stimulation (“PENFS”). The coverage sp ...

LONDON, Ontario, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the pricing of its underwritten U.S. public offering (the “Offering”) of 1,739,130 common shares, together with accompanying warrants to purchase 869,565 common sha ...

RONAN, Mont., Dec. 19, 2025 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) ("AirJoule Technologies" or "AIRJ"), a leading technology platform that unleashes the power of water from air, today announced a collaboration with the Red Dot Ranch Foundation (“Red Dot Ranch”) to bring cutting-edge off-grid water solutions to rural communities in coastal California. This positions the AirJoule™ platform technology to address critical water infrastructure gaps while demonstrating the commercial ...

VEON’s Mobilink Microfinance Bank Launches Islamic Banking Operations in Pakistan A new era of digital Islamic finance Dubai and Islamabad, December 19, 2025 – VEON Ltd. (Nasdaq: VEON), a global digital operator, announced today that its financial services subsidiary, Mobilink Microfinance Bank Ltd., has launched Islamic banking operations in Pakistan, expanding access to Shariah-compliant financial services in in response to growing customer demand. Mobilink Bank inaugurated its first dedicated Islami ...

– Bempedoic Acid Highlighted by ACC for LDL-C Lowering in Patients with Peripheral Artery Disease and Diabetes Based on Proven Cardiovascular and Limb Benefits – ANN ARBOR, Mich., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) welcomed the inclusion of bempedoic acid as a first-line, evidence-based therapy for LDL-C lowering for patients on maximally tolerated statins in the 2025 American College of Cardiology (ACC) Scientific Statement on Management of Peripheral Artery Disease (PAD) in Adults w ...

Smyrna, Delaware, Dec. 19, 2025 (GLOBE NEWSWIRE) -- AiRWA Inc. (Nasdaq: YYAI) (the “Company”), a technology licensing company developing a next-generation RWA-focused exchange for the trading of tokenized U.S. equities, today announced that it has entered into securities purchase agreements with investors for the purchase and sale of 15,382,378 shares of common stock at a purchase price of $1.02 per share, pursuant to a registered direct offering, resulting in gross proceeds of approximately $15.69 million, ...

$20.1 million upfront with a milestone-driven additional $20.1 million to advance INB-619, IN8bio’s novel gamma-delta (“γδ”) T cell engager through an Investigational New Drug (“IND”) application Financing led by Coastlands Capital with participation from new and existing biotechnology investors Initial proceeds extend cash runway into the first half of 2027 NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (“IN8Bio” or the “Company”) (Nasdaq: INAB), a clinical-stage biopharmaceutical company develo ...

New standalone mobile app applies DraftKings’ proven technology to event contracts, offering a streamlined experience and expanding the Company’s product portfolioBOSTON, Dec. 19, 2025 (GLOBE NEWSWIRE) -- DraftKings Inc. (NASDAQ: DKNG) (“DraftKings” or the “Company”) today announced the launch of DraftKings Predictions, formally entering prediction markets under the oversight of the U.S. Commodity Futures Trading Commission (CFTC). DraftKings Predictions is a new standalone mobile app and web product that a ...